SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-015525
Filing Date
2024-04-22
Accepted
2024-04-22 15:39:37
Documents
15
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 58718
2 ex31-1.htm EX-31.1 6864
3 ex31-2.htm EX-31.2 7004
  Complete submission text file 0001493152-24-015525.txt   365576

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bixt-20240331.xsd EX-101.SCH 25956
5 XBRL LABEL FILE bixt-20240331_lab.xml EX-101.LAB 99165
6 XBRL PRESENTATION FILE bixt-20240331_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 5969
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35027 | Film No.: 24861056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)